The SCG2 hormone allows tumors to suppress immune defenses, opening up a new therapeutic avenue against cancer.

A new Fred Hutch study surprisingly finds that many drugs initially written off as ineffective on cultured cancer cell lines ...

Animal studies say rapamycin can slow aging – but does it work in humans? A new review finds the evidence for the off-label, ...

Cambridge scientists built a two-part cancer drug that activates only in tumors with high enzyme levels, showing promise in ...

As it does with other pathogens, your immune system sees drugs as foreign invaders to be expelled from your body. But ...

Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...

A new study from Karolinska Institutet, published in Nature Communications, reveals that cyclin-dependent kinases (CDK) promote DNA replication licensing in human cells by relieving inhibitory signals ...

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment. Subscribe to our newsletter for the latest sci-tech news ...

Occasionally the food we eat can interfere with the way drugs are supposed to work. Now scientists are trying to harness these effects to boost the efficacy of treatments.

The cancer medication leucovorin shows potential benefits for autism spectrum disorder, improving communication skills in ...

Researchers have reported results from the first-ever clinical trial of a new class of targeted therapy in pet cats with head and neck squamous cell carcinoma (HNSCC)—a cancer which is notoriously ...